EQ vs LEN
Equillium Inc (EQ) versus LEN (LEN) — a side-by-side from cached financials, not a winner call.
Equillium Inc (EQ) is a biotechnology company listed on NASDAQ.
LEN (LEN) common stock.
Latest reported EQ revenue for 2024-12-31 was $41.1M. Net income was -$8.1M. Revenue was up 13.9% from 2023-12-31 to 2024-12-31. EQ currently screens at market cap $189.0M.
LEN does not have a complete income-statement cache yet.
EQ currently screens at market cap $189.0M. LEN currently screens at market cap $0.
Not investment advice. Open the EQ and LEN stock pages for the full models.
Not investment advice.